NCT06975085 2026-02-12
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study
University of Colorado, Denver
Phase 2 Completed
Clinical Trials
13 trialsNCT06703593 2025-10-01
Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients
British University In Egypt
Phase 2 Completed
NCT04126525 2025-09-11
NeoATP
RenJi Hospital
Phase 2 Active not recruiting
NCT05676255 2025-07-30
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
University of Arizona
Phase 2 Recruiting
NCT06176339 2024-03-15
Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"
Mansoura University
Phase 2 Active not recruiting
NCT05496101 2024-02-05
CLI-FAR
King's College London
Phase 2 Unknown
NCT05914831 2023-07-03
Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)
Oncology Institute of Vojvodina
Phase 2 Recruiting
NCT03917082 2023-06-15
LALEAST
British Columbia Cancer Agency
Phase 2 Active not recruiting
NCT03065621 2023-04-19
NeoRHEA
Jules Bordet Institute
Phase 2 Completed
NCT03383679 2022-11-21
START
UNICANCER
Phase 2 Completed
NCT04170465 2022-09-10
METNEO
Damanhour University
Phase 2 Completed
NCT03879174 2019-03-18
Pembro
Mediclinic Middle East
Phase 2 Unknown
NCT01204125 2017-03-22
SOLTI NEOPARP
Sanofi
Phase 2 Completed